Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

There will be lakhs of doctors, nurses, pharmacists and lab technologists. Of course, we will have surplus medicines manufactured in India to treat our population in 2050. That's all? What about the ...

The EMERALD trial investigators randomly assigned 478 patients with ER+, HER2- advanced breast cancer on a 1:1 basis to receive elacestrant or physician’s choice of standard therapy, which was defined ...